<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0192030.ref055">
 <label>55</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Theron</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Peter</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Dowdy</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Langley</surname>
   <given-names>I</given-names>
  </name>, 
  <name>
   <surname>Squire</surname>
   <given-names>SB</given-names>
  </name>, 
  <name>
   <surname>Dheda</surname>
   <given-names>K</given-names>
  </name>. 
  <article-title>Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?</article-title>
  <source>The Lancet infectious diseases</source>. 
  <year>2014</year>;
  <volume>14</volume>(
  <issue>6</issue>):
  <fpage>527</fpage>â€“
  <lpage>32</lpage>. Epub 2014/01/21. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1473-3099(13)70360-8" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S1473-3099(13)70360-8</ext-link>
  </comment> .
  <?supplied-pmid 24438820?>
  <pub-id pub-id-type="pmid">24438820</pub-id>
 </mixed-citation>
</ref>
